Trials / Recruiting
RecruitingNCT06546111
Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori Infection
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Sadat City University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study intends to assess the possible effectiveness and safety of Diosmin and Hesperidin combination in patients with Helicobacter pylori Infection through evaluating its effect on stool antigen test and serum levels of inflammatory biomarkers as(TNF-A and MDA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Drug :placebo tab PO BID for 14 days. |
| DRUG | Daflon | Daflon 500 mg tab PO BID for 14 days. |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-10-01
- Completion
- 2026-10-01
- First posted
- 2024-08-09
- Last updated
- 2024-08-12
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06546111. Inclusion in this directory is not an endorsement.